|
|
||||||||
Investigations of the duration of the prepatent period and of the early clinical course of falciparum malaria (McLendon strain) were conducted with 16 non-immune American Negro men. Eight of the men were glucose-6-phosphate dehydrogenase (G6PD)-deficient and 8 were not. The investigations did not disclose evidence supporting the hypothesis that G6PD deficiency confers a biologic advantage against falciparum malaria.
* These studies were supported, in major part, by the Medical Research and Development Command, Office of the Surgeon General, Department of the Army, under Contract DA-49-007-MD-566 with the University of Chicago, and, in part, by the Douglas Smith Foundation of the University of Chicago.
This article has been cited by other articles:
![]() |
L. Luzzatto, E. A. Usanga, and S. Reddy Glucose-6-Phosphate Dehydrogenase Deficient Red Cells: Resistance to Infection by Malarial Parasites Science, May 16, 1969; 164(3881): 839 - 842. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |